# Omega 3 Dry Eye Disease Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/omega-3-dry-eye-disease-meta-analysis-evidence-review
Category: evidence-review
Summary: Omega 3 Dry Eye Disease Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are m
Last reviewed: 2026-08-11
Reviewed by: Migaku Evidence Review
# Omega 3 Dry Eye Disease Meta-analysis: What the Evidence Says

## Quick Answer

Omega 3 Dry Eye Disease Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Advances in Pharmacotherapy and Physiotherapy for Dry Eye Disease: Molecular Mechanisms and Future Directions—A Narrative Literature Review | preclinical study | 4 | 2026-04-30 | 10.3390/ijms27094024 |
| The Effect of Nutrition on Dry Age-Related Macular Degeneration: A Systematic Narrative Review of Evidence and Clinical Implications | preclinical study | 4 | 2026-04-13 | 10.7759/cureus.106966 |

## What The Sources Report

- In particular, the estimated prevalence of DED increased to 61.0% globally and 56.7% in Asia during the COVID-19 pandemic, markedly higher than the levels prior to the pandemic, possibly due to the proliferation of remote work and online education. [Liu Jiaxiang (2026); evidence level 4]
- Additional contributing factors include incomplete blinking-often associated with prolonged screen use-and direct damage to the corneal epithelial glycocalyx. [Liu Jiaxiang (2026); evidence level 4]
- Although this form is less common, it is associated with a poorer prognosis and accounts for nearly 80% of severe vision loss caused by AMD. [Muacevic Alexander (2026); evidence level 4]
- The study concluded that consumption of the AREDS formula reduced the risk of progression by 25% over five years in patients with intermediate AMD or advanced disease in one eye. [Muacevic Alexander (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

For omega 3 dry eye disease meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Liu Jiaxiang (2026). Advances in Pharmacotherapy and Physiotherapy for Dry Eye Disease: Molecular Mechanisms and Future Directions—A Narrative Literature Review. DOI: 10.3390/ijms27094024. PMCID: PMC13163669. PMID: 42123603. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13163669/
- Muacevic Alexander (2026). The Effect of Nutrition on Dry Age-Related Macular Degeneration: A Systematic Narrative Review of Evidence and Clinical Implications. DOI: 10.7759/cureus.106966. PMCID: PMC13170399. PMID: 42137658. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13170399/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.